Caught before it produces symptoms, lung cancer may be successfully treated. LDCT screening from RAO has been proven superior to chest x-ray in the early discovery of lung cancer.
3D is the only mammography system FDA-approved as superior for the 47% of women with dense breast tissue, which is difficult to image using 2D mammography.
September is Prostate Cancer Awareness Month, read about the latest in advanced detection at RAO – the FDA-approved Illucix injectable tracer used with PET/CT imaging to provide excellent diagnostic accuracy, even in men with rising PSA levels.
Women who had a screening mammogram reveal something suspicious or are considered at high risk of breast cancer can benefit from the accuracy and detail of radiation-free breast MRI.
